+ Follow UPPSALA UNIVERSITY Tag
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 1386241
[Title] => Pag-inom ng gatas, nakakamatay?
[Summary] => Maraming nagsasabi na ang pag-inom ng gatas ay nakakapatibay ng buto.
[DatePublished] => 2014-10-31 00:00:00
[ColumnID] => 0
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Para Malibang
[SectionUrl] => para-malibang
[URL] =>
)
[1] => Array
(
[ArticleID] => 1369717
[Title] => Why you should keep plants in the office
[Summary] => We all know that adding few potted plants bring a comfortable feel to your work space. But apart from the visual appeal that plants provide, there are much more reasons why you should put a touch of green on your desk.
[DatePublished] => 2014-09-16 11:26:13
[ColumnID] => 0
[Focus] => 0
[AuthorID] => 1121281
[AuthorName] => Alixandra Caole Vila
[SectionName] => Health And Family
[SectionUrl] => health-and-family
[URL] => http://media.philstar.com/images/the-philippine-star/lifestyle/health-and-family/20140916/potted-plants-office.jpg
)
[2] => Array
(
[ArticleID] => 322917
[Title] => Pinoy docs in most extensive anti-blood clot clinical trial
[Summary] => Boehringer-Ingelheim has launched the biggest ever thromboembolic disease clinical trial program.
The trials under the umbrella name RE-VOLUTION and involving more than 27,000 patients worldwide, will investigate a novel oral direct thrombin inhibitor, dabigatran etexilate, researched and developed by the Germany-based pharmaceutical company to prevent and treat thromboembolic disease.
Dabigatran etexilate is a promising new oral direct thrombin inhibitor that specifically and reversibly inhibits thrombin, the key enzyme for blood clot formation.
[DatePublished] => 2006-02-23 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
)
)
UPPSALA UNIVERSITY
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 1386241
[Title] => Pag-inom ng gatas, nakakamatay?
[Summary] => Maraming nagsasabi na ang pag-inom ng gatas ay nakakapatibay ng buto.
[DatePublished] => 2014-10-31 00:00:00
[ColumnID] => 0
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Para Malibang
[SectionUrl] => para-malibang
[URL] =>
)
[1] => Array
(
[ArticleID] => 1369717
[Title] => Why you should keep plants in the office
[Summary] => We all know that adding few potted plants bring a comfortable feel to your work space. But apart from the visual appeal that plants provide, there are much more reasons why you should put a touch of green on your desk.
[DatePublished] => 2014-09-16 11:26:13
[ColumnID] => 0
[Focus] => 0
[AuthorID] => 1121281
[AuthorName] => Alixandra Caole Vila
[SectionName] => Health And Family
[SectionUrl] => health-and-family
[URL] => http://media.philstar.com/images/the-philippine-star/lifestyle/health-and-family/20140916/potted-plants-office.jpg
)
[2] => Array
(
[ArticleID] => 322917
[Title] => Pinoy docs in most extensive anti-blood clot clinical trial
[Summary] => Boehringer-Ingelheim has launched the biggest ever thromboembolic disease clinical trial program.
The trials under the umbrella name RE-VOLUTION and involving more than 27,000 patients worldwide, will investigate a novel oral direct thrombin inhibitor, dabigatran etexilate, researched and developed by the Germany-based pharmaceutical company to prevent and treat thromboembolic disease.
Dabigatran etexilate is a promising new oral direct thrombin inhibitor that specifically and reversibly inhibits thrombin, the key enzyme for blood clot formation.
[DatePublished] => 2006-02-23 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
)
)
abtest
October 31, 2014 - 12:00am
February 23, 2006 - 12:00am
